Sub-region based radiomics analysis for survival prediction in oesophageal tumours treated by definitive concurrent chemoradiotherapy

Abstract

Background Evaluating clinical outcome prior to concurrent chemoradiotherapy remains challenging for oesophageal squamous cell carcinoma (OSCC) as traditional prognostic markers are assessed at the completion of treatment. Herein, we investigated the potential of using sub-region radiomics as a novel tumour biomarker in predicting overall survival of OSCC patients treated by concurrent chemoradiotherapy. Methods Independent patient cohorts from two hospitals were included for training ( n = 87) and validation ( n = 46). Radiomics features were extracted from sub-regions clustered from patients' tumour regions using K-means method. The LASSO regression for ‘Cox’ method was used for feature selection. The survival prediction model was constructed based on the sub-region radiomics features using the Cox proportional hazards model. The clinical and biological significance of radiomics features were assessed by correlation analysis of clinical characteristics and copy number alterations(CNAs) in the validation dataset. Findings The overall survival prediction model combining with seven sub-regional radiomics features was constructed. The C-indexes of the proposed model were 0.729 (0.656–0.801, 95% CI) and 0.705 (0.628–0.782, 95%CI) in the training and validation cohorts, respectively. The 3-year survival receiver operating characteristic (ROC) curve showed an area under the ROC curve of 0.811 (0.670–0.952, 95%CI) in training and 0.805 (0.638–0.973, 95%CI) in validation. The correlation analysis showed a significant correlation between radiomics features and CNAs. Interpretation The proposed sub-regional radiomics model could predict the overall survival risk for patients with OSCC treated by definitive concurrent chemoradiotherapy. Fund This work was supported by the Zhejiang Provincial Foundation for Natural Sciences, National Natural Science Foundation of China.

Development and Validation of a Radiomics Nomogram Model for Predicting Postoperative Recurrence in Patients With Esophageal Squamous Cell Cancer Who Achieved pCR After Neoadjuvant Chemoradiotherapy Followed by Surgery

“…Second, the most useful predictive features based on the reproducible features identified in the previous step were selected using the least absolute shrinkage and selection operator (LASSO) Cox regression model (27,28), which is used to reduce high-dimensional data. Ten-fold cross-validation was used in the parameter tuning phase of the LASSO algorithm to extract the effective and predictive features (29).…”

Multi-Habitat Radiomics Unravels Distinct Phenotypic Subtypes of Glioblastoma with Clinical and Genomic Significance

“…The radiomics risk score for the i-th patient is the summation of radiomics features multiplied by the corresponding coefficients derived from Lasso-Cox regression analysis, where n is the number of features selected by LASSO, β j is the j -th weighted coefficient of the selected feature, and X ij is the j -th selected radiomic features for i -th patient. This method has been widely used in many radiomics studies encompassing various tumor types [ 19 , 20 , 21 , 22 ].…”

Imaging biomarkers of contrast-enhanced computed tomography predict survival in oesophageal cancer after definitive concurrent chemoradiotherapy

“…CT scans play an important role in the radiation treatment of OC, including diagnosis, staging, treatment planning, quality control, and follow-up. Non-contrast enhanced CT-based IBMs have been shown to be correlated with patient outcomes for a number of cancer types, including OSCC [ 18 , 20 ]. However, the most commonly available imaging modalities for patients after undergoing definitive CCRT were not non-contrast enhanced CT scans but contrast-enhanced CT scans, which were performed during treatment planning.…”